These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 33428978)

  • 1. Facial and neck erythema associated with dupilumab treatment: A systematic review.
    Jo CE; Finstad A; Georgakopoulos JR; Piguet V; Yeung J; Drucker AM
    J Am Acad Dermatol; 2021 May; 84(5):1339-1347. PubMed ID: 33428978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis.
    Jaros J; Hendricks AJ; Shi VY; Lio PA
    Dermatitis; 2020; 31(3):169-177. PubMed ID: 32355092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dupilumab facial redness: histologic characterization on a series of four cases.
    Dybała A; Sernicola A; Gomes V; Carnicelli G; Muharremi R; Grieco T
    Immunotherapy; 2022 Mar; 14(4):183-188. PubMed ID: 34933583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosacea associated with dupilumab therapy.
    Heibel HD; Hendricks AJ; Foshee JP; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
    [No Abstract]   [Full Text] [Related]  

  • 5. Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians.
    Muzumdar S; Skudalski L; Sharp K; Waldman RA
    Am J Clin Dermatol; 2022 Jan; 23(1):61-67. PubMed ID: 34855151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
    Yamane MLM; Belsito DV; Glass LRD
    Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort.
    Ordóñez-Rubiano MF; Casas M; Balaguera-Orjuela V
    Dermatol Ther; 2021 Nov; 34(6):e15140. PubMed ID: 34549488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facial erythema in patients with atopic dermatitis treated with Dupilumab - a descriptive study of morphology and Aetiology.
    Ahn J; Lee DH; Na CH; Shim DH; Choi YS; Jung HJ; Simpson EL
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2140-2152. PubMed ID: 35695074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Residual Facial Dermatitis during Dupilumab Therapy: A Retrospective Chart Review to Delineate the Potential Role of Expanded Series Patch Testing.
    Ashbaugh AG; Murase EM; Raffi J; Botto N; Murase JE
    Dermatitis; 2022 Jan-Feb 01; 33(1):51-61. PubMed ID: 35029349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series.
    de Wijs LEM; Nguyen NT; Kunkeler ACM; Nijsten T; Damman J; Hijnen DJ
    Br J Dermatol; 2020 Oct; 183(4):745-749. PubMed ID: 31749159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of dupilumab in patients with atopic dermatitis: expert opinion.
    Francuzik W; Alexiou A; Worm M
    Expert Opin Drug Saf; 2021 Sep; 20(9):997-1004. PubMed ID: 34114910
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysis.
    Halling AS; Loft N; Silverberg JI; Guttman-Yassky E; Thyssen JP
    J Am Acad Dermatol; 2021 Jan; 84(1):139-147. PubMed ID: 32822798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of dupilumab-associated conjunctivitis in atopic dermatitis.
    Aszodi N; Thurau S; Seegräber M; de Bruin-Weller M; Wollenberg A
    J Dtsch Dermatol Ges; 2019 May; 17(5):488-491. PubMed ID: 30873757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
    [No Abstract]   [Full Text] [Related]  

  • 16. Angioedema: A potential complication of dupilumab in atopic dermatitis.
    Fritz AL; Lacy FA; Morrell DS
    Pediatr Dermatol; 2021 Jan; 38(1):237-238. PubMed ID: 33099796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observation of the clinical features of dupilumab-associated facial erythema.
    Wu H; Zhang W; Wu Z; Shen Y; Zhang L; Yang M; Ren Y; Mao F
    Postepy Dermatol Alergol; 2023 Dec; 40(6):741-746. PubMed ID: 38282880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients.
    Guex-Crosier Y; Di-Lucca J; Häusermann P; Laffitte E; Saulite I; Schmid-Grendelmeier P; Schürch K; Thormann K; Simon D
    Swiss Med Wkly; 2021 Aug; 151():w30020. PubMed ID: 34495603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review.
    Raffi J; Suresh R; Botto N; Murase JE
    J Am Acad Dermatol; 2020 Jan; 82(1):132-138. PubMed ID: 31562940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records.
    Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA
    Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.